Evaluate Efficacy of Platelet Rich Plasma Therapy and Agnikarma in the Management of Plantar Fasciitis

A Randomized Comparative Clinical Trial to Evaluate Efficacy of Platelet Rich Plasma Therapy and Agnikarma in the Management of Plantar Fasciitis - NIL

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/11/097540

Enrollment

Registered

2025-11-17

Start date

Unknown

Completion date

Unknown

Last updated

2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M720- Palmar fascial fibromatosis [Dupuytren]

Interventions

Intervention1: Group B: Agnikarma: Procedure Details: The Lauha Shalaka will be heated by placing it on fire till it will become red hot Immediately Shalaka will be touched on marked 6 to 8 consecutiv

Eligibility

Inclusion criteria

Inclusion criteria: Patients presenting with Diagnostic criteria of Plantar Fasciitis Participants irrespective of gender, caste, religion and profession

Exclusion criteria

Exclusion criteria: Known case of comorbid conditions i.e. HTN, DM, Liver disease, Portal HTN, HIV and HBsAG Heel fractures or stress fractures Open wounds or ulcers in the affected foot Rheumatoid arthritis, psoriatic arthritis or other autoimmune diseases Long-term use of corticosteroid or strong opioids

Design outcomes

Primary

Measure	Time frame
Platelet Rich Plasma Therapy and Agnikarma will have effect in relieving Pain in HeelTimepoint: 28 Days	—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactDr Sanjay L Trivedi

G J Patel Institute of Ayurvedic Studies and Research

drsanjaytrivedi888@gmail.com8128012211

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026